Takuma Iwai

Dr. Takuma Iwai

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2018 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
Seiichi ShinjiSeiichi Shinji
Seiichi Shinji
YUYoshibumi Ueda
Yoshibumi Ueda
TYTakeshi Yamada
Takeshi Yamada
MKMichihiro Koizumi
Michihiro Koizumi
YYYasuyuki Yokoyama
Yasuyuki Yokoyama
HYHiroshi Yoshida
Hiroshi Yoshida
Anastomotic leakage (AL) is the most serious and common complication of surgery for rectal cancer, and associated risk factors remain unknown despite developments in laparoscopic surgery. The present study aimed to determine risk factors for AL after laparoscopic anterior resection (AR) of rectal cancer. This retrospective cohort study extracted information from a prospective database of all consecutive colorectal resections that proceeded at Nippon Medical School Hospital between January 2011 and December 2015 (n = 865). We identified 154 patients with rectal cancer treated by elective laparoscopic AR with anastomosis using primary double-stapling. Clinical variables and comorbidity, habits, and surgery-related variables were assessed by univariate and multivariate analyses to determine preoperative risk factors for clinical AL. The overall rate of clinical AL was 11.7% (18 of 154 patients), and 5 (27.8%) of 18 patients required revised laparotomy. Data from males were analyzed because AL occurred only in males. Univariate analysis of male patients (n = 100) significantly associated preoperative creatinine values (p = 0.03) and a history of ischemic heart disease (IHD) (p = 0.012) with AL. The frequency of AL tended to increase (p = 0.06) when patients had low AR (p = 0.06) and transanal drainage. Having AL significantly prolonged hospital stays compared with patients without leakage (36.2 vs. 11.1 days; p < 0.01). Multivariate analysis identified a history of IHD (odds ratio [OR], 4.73; 95% confidence interval [CI], 1.27–17.5; p = 0.025] as an independent risk factor for AL. Male sex and a history of IHD are possible risk factors for AL after elective laparoscopic rectal cancer surgery.

1 December 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
RORyo Ohta
Ryo Ohta
TYTakeshi Yamada
Takeshi Yamada
HSHiromichi Sonoda
Hiromichi Sonoda
AMAkihisa Matsuda
Akihisa Matsuda
Seiichi ShinjiSeiichi Shinji
Seiichi Shinji
HYHiroshi Yoshida
Hiroshi Yoshida

1 November 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
HSHiromichi Sonoda
Hiromichi Sonoda
TYTakeshi Yamada
Takeshi Yamada
AMAkihisa Matsuda
Akihisa Matsuda
RORyo Ohta
Ryo Ohta
Seiichi ShinjiSeiichi Shinji
Seiichi Shinji
HYHiroshi Yoshida
Hiroshi Yoshida

6 September 2017 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
TITakuma Iwai
Takuma Iwai
TYTakeshi Yamada
Takeshi Yamada
MKMichihiro Koizumi
Michihiro Koizumi
SSSeiichi Shinji
Seiichi Shinji
YYYasuyuki Yokoyama
Yasuyuki Yokoyama
EUEiji Uchida
Eiji Uchida

2 February 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
KUKoji Ueda
Koji Ueda
TYTakeshi Yamada
Takeshi Yamada
RORyo Ohta
Ryo Ohta
AMAkihisa Matsuda
Akihisa Matsuda
HSHiromichi Sonoda
Hiromichi Sonoda
HYHiroshi Yoshida
Hiroshi Yoshida

1 January 2025 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
GTGoro Takahashi
Goro Takahashi
TYTakeshi Yamada
Takeshi Yamada
KUKay Uehara
Kay Uehara
Seiichi ShinjiSeiichi Shinji
Seiichi Shinji
AMAkihisa Matsuda
Akihisa Matsuda
HYHiroshi Yoshida
Hiroshi Yoshida
INTRODUCTION: Anorectal malignant melanoma (ARMM) is an extremely rare and aggressive cancer that lacks specific tumor markers, making tumor dynamics difficult to monitor. Circulating tumor DNA (ctDNA), which contains cancer-specific gene mutations, has emerged as a promising biomarker for monitoring various malignant tumors. We herein report the clinical utility of ctDNA measurements in 2 patients with ARMM.CASE PRESENTATION: Case 1: A 64-year-old woman diagnosed with clinical Stage III ARMM underwent laparoscopic abdominoperineal resection with lateral lymph node dissection. Pathological findings confirmed R0 resection, and genetic analysis identified a neuroblastoma RAS viral (v-ras) oncogene homologue (NRAS) mutation (p.G12S). She remained recurrence-free for 7 years postoperatively. In a longitudinal ctDNA study, the preoperative ctDNA level (28.7 copies/mL) became undetectable after curative resection and remained undetectable throughout follow-up. By contrast, lactate dehydrogenase (LDH) currently the only blood-based tumor marker for mucosal melanoma, including ARMM, remained within the normal range (124–222 U/L) both preoperatively and postoperatively. Case 2: A 69-year-old woman diagnosed with clinical Stage III ARMM underwent laparoscopic abdominoperineal resection with lateral lymph node dissection. Pathological findings confirmed R0 resection, and genetic analysis identified two KIT proto-oncogene receptor tyrosine kinase (KIT) mutations (p.Y553H and p.Y646C) in exons 11 and 13. One year postoperatively, lung metastases were confirmed via positron emission tomography-computed tomography, and nivolumab monotherapy was initiated. The lung metastases remained stable for 7 months. In a longitudinal ctDNA study, the preoperative ctDNA level (28.7 copies/mL) became undetectable following curative resection. However, ctDNA re-emerged (9.05 and 7.2 copies/mL, respectively) at the time of lung metastasis detection. After initiating nivolumab treatment, ctDNA again became undetectable. Throughout the clinical course, the LDH level remained consistently within the normal range.CONCLUSIONS: We demonstrated the utility of ctDNA monitoring in patients with ARMM, a rare tumor. This method has the potential to be applied to other rare tumors if tumor-specific mutations can be identified.